Sveriges mest populära poddar
The Genetics Podcast
VetenskapNaturvetenskap

EP 84: Mark Kotter, CEO, and Founder of bit.bio, on creating every cell type and kickstarting a cell therapy revolution

35 min•1 september 2022
Doctors have been transplanting organs for decades, but can we transplant reprogrammed stem cells to rejuvenate the human body? This week Patrick discusses transcriptional reprogramming, and bit.bio's opti-ox technology that has the potential to create every cell type and help kickstart a cell therapy revolution. With Mark Kotter Ph.D., neurosurgeon, and CEO and Founder of bit.bio.

Fler avsnitt av The Genetics Podcast

Visa alla avsnitt av The Genetics Podcast
EP 233: Unlocking early detection in liver disease with data and genetics with Tim Jobson of Predictive Health Intelligence
•33 min
EP 232: How ethics and law shape reproductive technology and AI in medicine with Glenn Cohen of Harvard Law School
•24 min
EP 231: From polygenic scores to AI-driven medicine with Andrea Ganna of the Institute for Molecular Medicine Finland
•36 min
EP 230: From short reads to long reads in clinical genomics with Anna Lindstrand of Karolinska Institute
•40 min
EP 229: Turning personal tragedy into a movement for preventive genetics with Matthew Goldstein of jscreen
•40 min
EP 228: What genomes reveal about Epstein–Barr virus and human disease with Ryan Dhindsa and Caleb Lareau
•46 min
EP 227: Discovering a new neurodevelopmental syndrome in the non-coding genome with Nicky Whiffin of the University of Oxford
•43 min
EP 226: Scaling AAV gene therapy: Engineering delivery, safety, and cost with David Dismuke of Forge Biologics and Steven Gray of UT Southwestern
•39 min
EP 225: Lessons from 20 years of building ocular gene therapies with Daniel Chung of Beacon Therapeutics
•37 min
EP 224: Genomic newborn screening in Australia: From pilot studies to population-scale programs with Zornitza Stark of the University of Melbourne
•44 min

The Genetics Podcast med Sano Genetics finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.